Frequency, causes and phenomenology of late seizure recurrence in patients with juvenile myoclonic epilepsy after a long period of remission

Seizure

Volumn 16, Issue 6, 2007, Pages 533-537

  Sokic, Dragoslav ^a   Ristic, Aleksandar J ^a   Vojvodic, Nikola ^a   Jankovic, Slavko ^a   Sindjelic, Aleksandra R ^a  

^a Institute of Neurology   (Yugoslavia)

Author keywords

JME; Provoking factors; Remission; Seizure recurrence; Treatment

Indexed keywords

CLOBAZAM; LAMOTRIGINE; PHENOBARBITAL; TOPIRAMATE; VALPROIC ACID;

ABSENCE; ADULT; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; FEMALE; FOLLOW UP; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MENSTRUATION; MONOTHERAPY; MYOCLONUS EPILEPSY; MYOCLONUS SEIZURE; PATIENT COMPLIANCE; PHOTOSTIMULATION; PLASMA HALF LIFE; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; SEIZURE; SLEEP DEPRIVATION; TONIC CLONIC SEIZURE;

ADOLESCENT; ADULT; AGE OF ONSET; ELECTROENCEPHALOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MYOCLONIC EPILEPSY, JUVENILE; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; SEIZURES; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 34547691036     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2007.03.012     Document Type: Article

References (13)

1. Schmitz B., and Sander T. Juvenile myoclonic epilepsy: the Janz syndrome (2000), Wrighton Biomedical Publishing Ltd., Petersfield
2. Matsuoka H. The seizure prognosis of juvenile myoclonic epilepsy. Jpn J Psychiatry Neurol 46 (1992) 293-296
3. Panayiotopoulos C.P., Obeid T., and Tahan A.R. Juvenile myoclonic epilepsy: a 5-year prospective study. Epilepsia 35 (1994) 285-296
4. Panayiotopoulos C.P. Juvenile myoclonic epilepsy (Janz syndrome). In: Panayiotopoulos C.P. (Ed). The epilepsies: seizures, syndromes and management based on the ILAE classifications and practice parameter guidelines (2005), Blandon Medical Publishing, Oxfordshire 308-321
5. Vijai J., Cherian P.J., Stlaja P.N., Anand A., and Radhakrishnan K. Clinical characteristics of South Indian cohort of juvenile myoclonic epilepsy probands. Seizure 12 (2003) 490-496
6. Calleja S., Salas-Puig J., Ribacoba R., and Lahoz C.H. Evolution of juvenile myoclonic epilepsy treated from the outset with sodium valproate. Seizure 10 (2001) 424-427
7. Gunatilake S.B., and Seneviratne S.L. Juvenile myoclonic epilepsy: a study in Sri Lanka seizure 9 (2000) 221-223
8. Montalenti E., Imperiale D., Rovera A., Bergamasco B., and Benna P. Clinical features, EEG findings and diagnostic pitfalls in juvenile myoclonic epilepsy: a series of 63 patients. J Neurol Sci 184 (2000) 65-70
9. Janz D. Epilepsy with impulsive petit mal (juvenile myoclonic epilepsy). Acta Neurol Scand 72 (1985) 449-459
10. Penry J.K., Dean J.C., and Riela A.R. Juvenile myoclonic epilepsy: long-term response to therapy. Epilepsia 30 Suppl. 4 (1989) S19-S23
11. Appleton R., Beirne M., and Acomb B. Photosensitivity in juvenile myoclonic epilepsy. Seizure 9 (2000) 108-111
12. Ercegovac M.D., Vojvodic N., Sokic D.V., Jankovic S.M., Drulovic J., Stojsavljevic N., and Levic Z. Juvenile myoclonic epilepsy. Srp Arh Celok Lek 126 (1998) 335-344
13. Ristic A.J., Vojvodic N., Sindjelic A., Jankovic S., and Sokic D. The frequency of reversible Parkinsonism and cognitive decline associated with valproate treatment: a study of 364 patients with different types of epilepsy. Epilepsia 47 (2006) 2183-2185